Adeline Vanderver MD
Assistant Professor, Neurology, G Washington University School of Medicine & Hlth Sci
Join to View Full Profile
3401 Civic Center BlvdPhiladelphia, PA 19104
Phone+1 215-590-1000
Fax+1 215-590-1771
Dr. Vanderver is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's National Hospital/George Washington UniversityFellowship, Child Neurology, 2001 - 2004
Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonResidency, Pediatrics, 1999 - 2001
Temple University HospitalInternship, Pediatrics, 1998 - 1999
University Cath De LouvainClass of 1998
Certifications & Licensure
PA State Medical License 1999 - 2026
VA State Medical License 2022 - 2026
MD State Medical License 2004 - 2025
NJ State Medical License 2022 - 2025
NC State Medical License 2022 - 2024
NY State Medical License 2022 - 2023
DC State Medical License 2004 - 2020
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- The Nosology and Etiology of Leukodystrophies of Unknown Causes Start of enrollment: 2009 Apr 24
- Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis Start of enrollment: 2011 Oct 01
- Natural History Study of Children With Metachromatic Leukodystrophy Start of enrollment: 2015 Nov 02
- Join now to see all
Publications & Presentations
PubMed
- Tofacitinib treatment for psoriatic skin lesions associated with Aicardi-Goutières syndrome 7/Singleton-Merten syndrome 1.Shanice Beerepoot, Lucas Grinwis, Adeline L Vanderver, Marjo S van der Knaap, Taco W Kuijpers
Orphanet Journal of Rare Diseases. 2025-04-02 - Effective gene therapy for metachromatic leukodystrophy achieved with minimal lentiviral genomic integrations.Lucas Tricoli, Sunetra Sase, Julia L Hacker, Vi Pham, Maxwell Chappell
Molecular Therapy. Nucleic Acids. 2025-03-11 - Using multiple modalities to confirm diagnosis in patients with suspected peroxisome biogenesis disorders.Anthony C T Cheung, Erminia Di Pietro, Catherine Argyriou, Eric Bareke, Yasmin D'Souza
Molecular Genetics and Metabolism. 2025-03-11
Journal Articles
- Author Correction: Neuroimmune Disorders of the Central Nervous System in Children in the Molecular EraAdeline Vanderver, Beau Ances, Benjamin Greenberg, Ann Hyslop, Mark Gorman, Elizabeth Wells, Sean Pittock, Amy Waldman, Brenda Banwell, Nature
- Health-Related Quality of Life for Patients with Genetically Determined LeukoencephalopathyAdeline Vanderver, Raphael Schiffmann, Pediatric Neurology
Authored Content
- Health-Related Quality of Life for Patients with Genetically Determined LeukoencephalopathyMay 2018
Press Mentions
Preclinical Study Demonstrates Improved Gene Therapy Approach to Treating a Rare and Devastating Disease in ChildrenMarch 12th, 2025
Existing Drugs May Improve Neurological Function in Patients with Rare Genetic DisorderSeptember 2nd, 2020
My Girl, 11, Can’t Walk After a Rare Disease Robbed Her of Her Future – Now I’ve Helped Raise £75k to Help Find a CureAugust 11th, 2020- Join now to see all
Grant Support
- Molecular Mechanisms In Vanishing White Matter DiseaseNational Institute Of Neurological Disorders And Stroke2009–2012
- New Diagnostic Approaches In LeukodystrophyNational Center For Research Resources2007–2008
- Improved Diagnosis Of Unclassified LeukodystrophiesNational Center For Research Resources2006–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
